NR4A1 and breast cancer: When assessing acceptance rates by hormone receptor status, active steps towards the offered strategy for ovarian function and/or fertility preservation were pursued by 119 out of 124 (96%) women with hormone receptor-positive breast cancer and by 32 out of 35 (91.4%) with hormone receptor-negative breast cancer.